Skip to the page

Data / Drug companies / Paricalcitol

Paricalcitol: 13 companies and 39 products in the FDA NDC directory

Paricalcitol is listed in the FDA National Drug Code Directory by 13 companies, with 39 products in commercial distribution. 30 of the products (76.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, liquid filled; injection; capsule, and the newest product started marketing on October 9, 2018.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
13
Products
39
Generic (ANDA) products
30 (76.9%)
Application numbers
11
Routes
Oral, Intravenous
Brand names
Zemplar
openFDA record search
api.fda.gov

Companies that list paricalcitol

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
AbbVie Inc.4injection, solution; capsule, liquid filledNew drug applications (NDA)April 20, 2018
Amneal Pharmaceuticals LLC4injectionGeneric drugs (ANDA)March 9, 2017
Eugia US LLC4injectionGeneric drugs (ANDA)October 9, 2018
Amneal Pharmaceuticals LLC3capsuleGeneric drugs (ANDA)January 15, 2016
Aurobindo Pharma Limited3capsule, liquid filledGeneric drugs (ANDA)January 14, 2016
Bionpharma Inc.3capsuleGeneric drugs (ANDA)August 16, 2016
Dr. Reddy's Laboratories Limited3capsule, liquid filledGeneric drugs (ANDA)June 25, 2014
Hikma Pharmaceuticals USA Inc.3injectionNew drug applications (NDA)November 18, 2014
Marksans Pharma Limited3capsule, liquid filledGeneric drugs (ANDA)December 31, 2016
Time Cap Laboratories, Inc3capsule, liquid filledGeneric drugs (ANDA)January 3, 2017
Accord Healthcare Inc.2injection, solutionNew drug applications (NDA)March 24, 2016
Bryant Ranch Prepack2capsuleGeneric drugs (ANDA)August 16, 2016
Bryant Ranch Prepack2capsuleGeneric drugs (ANDA)August 16, 2016

Dosage forms

Dosage formProductsShare
Capsule, liquid filled1435.9%
Injection1128.2%
Capsule1025.6%
Injection, solution410.3%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3076.9%
New drug applications (NDA)923.1%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.